HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Market Intelligence

Set Alert for Market Intelligence

For Switch Success, Dive Deeper Into Consumer Behaviour

Behavioral insights can help companies make a success of Rx-to-OTC switches, explains Hamell’s managing director Fiona Hammond, in an exclusive interview with HBW Insight. 

Health OTC Drugs

Health And Wellness Trademark Review 7 January, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
OTC Drugs Dietary Supplements

Digital Advances In Consumer Health At CES: Oral Care, Nausea, Beauty Products

OTC drug, supplement and beauty firms are spreading into digital health devices showcased at the 2020 Consumer Electronics Show as technological advancements help consumers reach health and wellness goals. Colgate debuted a smart toothbrush that detects biofilm build-up while L’Oreal introduced AI-powered skin care.

OTC Devices Commercial

EU Wellness Market In 2019: The CBD Green Rush

INFOGRAPHIC: An interactive timeline of HBW Insight's coverage of the blossoming European CBD market in 2019. The timeline covers the main events of the year beginning with the European Commission's decision to classify CBD as a novel food, and ending on the filing of the first application for a synthetic form of the cannabis-derived ingredient.
Market Intelligence Europe

Cosmetics Weekly Trademark Review: 17 December 2019

Personal-care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps.
Cosmetics Commercial

Supplement GMP Documentation Better, But Still No. 2 On FDA Observation List – AHPA

FDA revisits about a third of supplement manufacturing sites, with two-thirds coming within three years, says AHPA. Chief information analyst Merle Zimmermann says FDA increased focus on recordkeeping has resulted in an improvement and fewer problems reported since 2015

Dietary Supplements FDA
See All